The Cooper Companies, Inc. (COO) vs Madrigal Pharmaceuticals, Inc. (MDGL)

A side-by-side comparison of The Cooper Companies, Inc. and Madrigal Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — COO vs MDGL

growth of $100 · dividends reinvested · last 10y
COO +29.2% (+2.6%/yr)MDGL +2930.2% (+40.7%/yr)MDGL compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $10020182020202220242026$129$3,030
COO MDGL

COO vs MDGL: by the numbers

  • •MDGL is the larger company ($11.46B vs $10.98B market cap).
  • •COO is profitable (13.46% net margin) while MDGL runs a net loss (-25.32%).

Metrics side by side

Valuation

MetricCOOMDGL
P/E ratio19.21N/A
Forward P/E12.39N/A
P/S ratio2.598.93
P/B ratio1.3221.89
EV / EBITDA14.40N/A
FCF yield6.18%N/A

Profitability

MetricCOOMDGL
Gross margin63.64%91.48%
Operating margin12.85%-25.13%
Net margin13.46%-25.32%
ROE6.85%-62.07%
ROIC4.76%-37.02%

Growth (annualized)

MetricCOOMDGL
Revenue CAGR (5Y)8.29%N/A
EPS CAGR (5Y)-17.30%N/A
FCF CAGR (5Y)5.21%N/A
Total return CAGR (5Y)-11.35%44.41%

Frequently asked

Is COO or MDGL more profitable?
COO runs the higher net margin — COO at 13.46% versus MDGL at -25.32%.
How have COO and MDGL total returns compared?
Over the past 10 years, COO delivered 2.53% and MDGL delivered 41.50% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.